What is the latest price of capmatinib in 2024?

Capmatinib (Capmatinib) is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Capmatinib belongs to the kinase inhibitor class of drugs. It works by blocking the activity of an abnormal protein that sends a reproduction signal to cancer cells, which helps slow or prevent the spread of cancer cells.

Capmatinib is available as an oral tablet. Usually twice a day, with or without food. Take capmatinib at about the same time each day, and do not take more or less often than prescribed by your doctor. Swallow the tablets whole; do not cut, chew, or crush them. If a patient vomits after taking capmatinib, do not take additional doses. Continue regular dosing schedule. During treatment, doctors may need to temporarily or permanently stop the drug or reduce the dose, depending on how well capmatinib works for the patient and the side effects experienced.

The original drug capmatinib has not yet been launched in the domestic market, so it is not covered by medical insurance. In Hong Kong, the price of each box of 200 mg 60 strength medicines is as high as more than 30,000 yuan; in overseas markets, the European version of the 200 mg 120 strength original medicine is priced at more than 50,000 yuan per box. It may also fluctuate due to exchange rates, which is indeed expensive. However, there are also more affordable generic capmatinib drugs available overseas. The ingredients of the drug are basically the same as those of the original drug. For example, the 200mg*56 size drug produced in Laos only costs more than 3,000 yuan per box. Although the price may also be affected by the exchange rate, it has been greatly reduced compared to the original drug. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.